Other Open Access

Table I: Evolution of the subgroup RMITT-2 (number of participants, efficacy) / Table II: Evolution and changes in the definition of subgroup RMITT-2

Catherine Riva; Jean-Pierre Spinosa; Serena Tinari

Data submitted by Merck to the Food and Drug Administration (FDA) for Gardasil® approval (published and unpublished data). These tables show that the definition of the subgroup “negative to 14 HPV types” population (RMITT-2) changed several times between 2006 and 2010.

Files (149.9 kB)
Name Size
Tables-RMITT-2.pdf
md5:24f2bd3bc903aa0db7fcee42f7d9e260 		149.9 kB Download
139
58
views
downloads
All versions This version
Views 139139
Downloads 5858
Data volume 8.7 MB8.7 MB
Unique views 124124
Unique downloads 5050
More info on how stats are collected.
Indexed in
Publication date:
June 4, 2018
DOI:
10.5281/zenodo.1434229

Zenodo DOI Badge

DOI 

10.5281/zenodo.1434229

Markdown 

[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.1434229.svg)](https://doi.org/10.5281/zenodo.1434229)

reStructedText 

.. image:: https://zenodo.org/badge/DOI/10.5281/zenodo.1434229.svg
   :target: https://doi.org/10.5281/zenodo.1434229

HTML 

<a href="https://doi.org/10.5281/zenodo.1434229"><img src="https://zenodo.org/badge/DOI/10.5281/zenodo.1434229.svg" alt="DOI"></a>

Image URL 

https://zenodo.org/badge/DOI/10.5281/zenodo.1434229.svg

Target URL 

https://doi.org/10.5281/zenodo.1434229

Keyword(s):
HPV vaccine Gardasil RMITT-2 Post-hoc subgroupe analysis
License (for files):
Creative Commons Attribution 4.0 International

Versions

Version 1 10.5281/zenodo.1434229 Jun 4, 2018
Cite all versions? You can cite all versions by using the DOI 10.5281/zenodo.1434228. This DOI represents all versions, and will always resolve to the latest one. Read more.

Share

Cite as

Export